Cargando…
Human APOBEC3B promotes tumor heterogeneity in vivo including signature mutations and metastases
The antiviral DNA cytosine deaminase APOBEC3B has been implicated as a source of mutation in many different cancers. Despite over 10 years of work, a causal relationship has yet to be established between APOBEC3B and any stage of carcinogenesis. Here we report a murine model that expresses tumor-lik...
Autores principales: | Durfee, Cameron, Temiz, Nuri Alpay, Levin-Klein, Rena, Argyris, Prokopios P., Alsøe, Lene, Carracedo, Sergio, de la Vega, Alicia Alonso, Proehl, Joshua, Holzhauer, Anna M., Seeman, Zachary J., Lin, Yu-Hsiu T., Vogel, Rachel I., Sotillo, Rocio, Nilsen, Hilde, Harris, Reuben S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980288/ https://www.ncbi.nlm.nih.gov/pubmed/36865194 http://dx.doi.org/10.1101/2023.02.24.529970 |
Ejemplares similares
-
Human APOBEC3B promotes tumor development in vivo including signature mutations and metastases
por: Durfee, Cameron, et al.
Publicado: (2023) -
DNA Deamination Is Required for Human APOBEC3A-Driven Hepatocellular Carcinoma In Vivo
por: Naumann, Jordan A., et al.
Publicado: (2023) -
APOBEC3A catalyzes mutation and drives carcinogenesis in vivo
por: Law, Emily K., et al.
Publicado: (2020) -
Mutation Signatures Including APOBEC in Cancer Cell Lines
por: Jarvis, Matthew C, et al.
Publicado: (2018) -
Acute expression of human APOBEC3B in mice results in RNA editing and lethality
por: Alonso de la Vega, Alicia, et al.
Publicado: (2023)